Sommaire

• • ·Table of Contents

    Page :i

    
• • ·Editorial Board

    Page :iii

    
• • ·Information for Readers

    Page :iv

    

• Results of Expert Meetings

  • ·Countering clinical inertia in lipid management: Expert workshop summary

    Page :24-29

    Leah L. Zullig, Lisa Egbuonu-Davis, Anjali Trasy, Christiana Oshotse, Karen M. Goldstein, Hayden B. Bosworth

    Plan Plan  

• Curriculum in Cardiology

  • ·Recovery of failing hearts by mechanical unloading: Pathophysiologic insights and clinical relevance

    Page :30-50

    Michael Dandel, Roland Hetzer

    Résumé Résumé Plan Plan  

• Trial Designs

  • ·Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)

    Page :11-23

    Christopher P. Cannon, Darren K. McGuire, Richard Pratley, Sam Dagogo-Jack, James Mancuso, Susan Huyck, Bernard Charbonnel, Weichung J. Shih, Silvina Gallo, Urszula Masiukiewicz, Gregory Golm, Francesco Cosentino, Brett Lauring, Steven G. Terra, VERTIS-CV Investigators

    Résumé Résumé Plan Plan  
  • ·The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conduct

    Page :72-79

    Philip Joseph, Prem Pais, Antonio L Dans, Jackie Bosch, Denis Xavier, Patricio Lopez-Jaramillo, Khalid Yusoff, Anwar Santoso, Shamim Talukder, Habib Gamra, Karen Yeates, Paul Camacho Lopez, Jessica Tyrwhitt, Peggy Gao, Koon Teo, Salim Yusuf, on behalf of the TIPS-3 Investigators

    Résumé Résumé Plan Plan   
  • ·Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

    Page :80-93

    Aruna D. Pradhan, Nina P. Paynter, Brendan M. Everett, Robert J. Glynn, Pierre Amarenco, Marshall Elam, Henry Ginsberg, William R. Hiatt, Shun Ishibashi, Wolfgang Koenig, Børge G. Nordestgaard, Jean-Charles Fruchart, Peter Libby, Paul M Ridker

    Résumé Résumé Plan Plan   
  • ·A randomized clinical trial of early invasive intervention for atrial fibrillation (EARLY-AF) - methods and rationale

    Page :94-104

    Jason G. Andrade, Jean Champagne, Marc W. Deyell, Vidal Essebag, Sandra Lauck, Carlos Morillo, John Sapp, Alan Skanes, Patricia Theoret-Patrick, George A. Wells, Atul Verma, for the EARLY-AF Study Investigators

    Résumé Résumé Plan Plan   

• Clinical Investigations

  • ·Thirty-day outcomes in patients with acute pulmonary embolism who discontinued anticoagulant therapy before 90 days

    Page :1-10

    José A. Nieto, Julio A. Vicente, Luis M. Prieto, David Jiménez, Behnood Bikdeli, Agustina Rivas, José Antonio Porras, Mª del Valle Morales, Marijan Bosevski, Manuel Monreal, RIETE Investigators 1

    Résumé Résumé Plan Plan  
  • ·Sex differences in long-term outcomes of patients across the spectrum of coronary artery disease

    Page :51-60

    Neha J. Pagidipati, Daniel W. Mudrick, Karen Chiswell, Amanda Brucker, Eric D. Peterson, Pamela S. Douglas

    Résumé Résumé Plan Plan   
  • ·The East–West late lumen loss study: Comparison of angiographic late lumen loss between Eastern and Western drug-eluting stent study cohorts

    Page :61-71

    Robert W. Harrison, Vaishnavi Radhakrishnan, John C. Allen, Peter S. Lam, Dominic J. Allocco, Sandeep Brar, Martin Fahy, Zhen Zhang, Rebecca Fisher, Fumiaki Ikeno, Philippe Généreux, Takeshi Kimura, Minglei Liu, Weng Kit Lye, Hirofumi Nagai, Yuka Suzuki, Roseann White, Mitchell W. Krucoff

    Résumé Résumé Plan Plan  
  • ·Risk stratification and clinical outcomes after surgical pulmonary valve replacement

    Page :105-112

    Alexander C. Egbe, William R. Miranda, Sameh M. Said, Sorin V. Pislaru, Patricia A. Pellikka, Barry A. Borlaug, Srikanth Kothapalli, Heidi M. Connolly

    Résumé Résumé Plan Plan   

• Policy Perspectives

  • ·The relationship between pharmacy benefit managers (PBMs) and the cost of therapies in the US pharmaceutical market: A policy primer for clinicians

    Page :113-122

    Kevin A. Schulman, Matan Dabora

    Résumé Résumé Plan Plan   

• Research Letters

  • ·Long-term mortality and estimated functional capacity among women with symptoms of ischemic heart disease: From the NHLBI-sponsored Women's Ischemia Syndrome Evaluation

    Page :123-126

    Islam Y. Elgendy, Hend Mansoor, Qian Li, Yi Guo, Eileen M. Handberg, C. Noel Bairey Merz, Carl J. Pepine

    Résumé Résumé Plan Plan   
  • ·Randomized trial of rivaroxaban versus warfarin in the evaluation of progression of coronary atherosclerosis

    Page :127-130

    Juhwan Lee, Rine Nakanishi, Dong Li, Kashif Shaikh, Chandana Shekar, Kazuhiro Osawa, Negin Nezarat, Eranthi Jayawardena, Maja Blanco, Matthew Chen, Matthew Sieckert, Eric Nelson, Darius Billingsley, Sajad Hamal, Matthew J. Budoff

    Résumé Résumé Plan Plan  
  • ·Patterns of use of targeted temperature management for acute myocardial infarction patients following out-of-hospital cardiac arrest: Insights from the National Cardiovascular Data Registry

    Page :131-133

    Christopher B. Fordyce, Anita Y. Chen, Tracy Y. Wang, Joseph Lucas, Abhinav Goyal, Graham C. Wong, Sean van Diepen, Michael C. Kontos, Timothy D. Henry, Christopher B. Granger, Matthew T. Roe

    Résumé Résumé Plan Plan